Concepedia

Author

Luciano Vellón

Institut Català d'Oncologia

Also Known As

L Vellón, L. VELLON, L. Vellon, L. Vellón, Luciano Vellon, Luciano Vellón, Vellón, Luciano

67

Publications

3K

Citations

29

H-Index

90

Concepts

All Affiliations

Institut Català d'OncologiaNorthwestern UniversityInstitut d'Investigació Biomèdica de GironaNorthShore University HealthSystemConsejo Nacional de Investigaciones Científicas y Técnicas
LV

About

Luciano Vellón is an author at Institut Català d'Oncologia specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

20

1.5K

2

Natural Sciences

3

3

62

3

Health Sciences

2

2

55

4

Engineering

1

1

17

5

Social Sciences

1

1

47

Luciano Vellón

×

39

Publications

2.6K

Citations

27

H-Index

YearCitations

Inhibition of fatty acid synthase (FAS) suppresses<i>HER2/neu</i>(<i>erb</i>B-2) oncogene overexpression in cancer cells

Javier A. Menéndez, Luciano Vellón, Inderjit Mehmi,

Proceedings of the National Academy of Sciences

2004

318

Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin™) in breast cancer cells with Her-2/neu oncogene amplification

Javier A. Menéndez, Luciano Vellón, Rámón Colomer,

Annals of Oncology

2005

260

Autophagy positively regulates the CD44<sup>+</sup>CD24<sup>-/low</sup>breast cancer stem-like phenotype

Sílvia Cufí, Alejandro Vázquez‐Martín, Cristina Oliveras‐Ferraros,

Cell Cycle

2011

182

Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene

Javier A. Menéndez, Luciano Vellón, Ruth Lupu

Annals of Oncology

2005

177

A novel CYR61-triggered ‘CYR61-αvβ3 integrin loop’ regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway

Javier A. Menéndez, Luciano Vellón, Inderjit Mehmi,

Oncogene

2004

153

Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: New insight into the role of mitophagy in cell stemness

Alejandro Vázquez‐Martín, Sílvia Cufí, Bruna Corominas-Faja,

Aging

2012

119

A genomic explanation connecting “Mediterranean diet”, olive oil and cancer: Oleic acid, the main monounsaturated Fatty acid of olive oil, induces formation of inhibitory “PEA3 transcription factor-PEA3 DNA binding site” complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells

Javier A. Menéndez, Adriana Papadimitropoulou, Luciano Vellón,

European Journal of Cancer

2006

115

Pharmacological and small interference RNA‐mediated inhibition of breast cancer‐associated fatty acid synthase (oncogenic antigen‐519) synergistically enhances Taxol (paclitaxel)‐induced cytotoxicity

Javier A. Menéndez, Luciano Vellón, Rámón Colomer,

International Journal of Cancer

2005

108

Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway

Bruna Corominas-Faja, Sílvia Cufí, Cristina Oliveras‐Ferraros,

Cell Cycle

2013

105

Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells

Alejandro Vázquez‐Martín, Luciano Vellón, Pedro M. Quirós,

Cell Cycle

2012

97

Page 1